RNTX
Income statement / Annual
Last year (2025), Rein Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Rein Therapeutics Inc.'s net income was -$49.87 M.
See Rein Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$1.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.03 M
|
$14.25 M
|
$3.99 K
|
$17.97 K
|
$17.01 K
|
$11.17 K
|
| General & Administrative Expenses |
$10.90 M
|
$13.86 M
|
$11.36 K
|
$9.68 K
|
$9.60 K
|
$9.33 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.90 M
|
$13.86 M
|
$11.36 K
|
$9.68 K
|
$9.60 K
|
$9.33 K
|
| Other Expenses |
-$1.00 K
|
$37.00 M
|
$928.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$21.93 M
|
$65.11 M
|
$16.28 K
|
$27.65 K
|
$26.61 K
|
$20.50 K
|
| Cost And Expenses |
$21.93 M
|
$65.11 M
|
$16.28 K
|
$27.65 K
|
$26.61 K
|
$20.50 K
|
| Interest Income |
$0.00
|
$400.00 K
|
$600.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.00 K
|
$63.00 K
|
$119.00
|
$169.00
|
$121.00
|
$163.00
|
| EBITDA |
-$21.93 M |
-$28.05 M |
-$15.23 K |
-$27.48 K |
-$26.48 K |
-$20.33 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$28.65 M
|
$800.00 K
|
$544.00
|
$318.00
|
$441.00
|
-$661.00
|
| Income Before Tax |
-$50.58 M
|
-$64.31 M
|
-$15.73 K
|
-$27.33 K
|
-$26.16 K
|
-$21.16 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$712.00 K
|
-$1.54 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$49.87 M
|
-$62.88 M
|
-$15.73 K
|
-$27.33 K
|
-$26.16 K
|
-$21.16 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.96 |
-3.51 |
-3.42 |
-6.02 |
-5.89 |
-0.0012 |
| EPS Diluted |
-1.96 |
-3.51 |
-3.42 |
-6.02 |
-5.89 |
-0.0012 |
| Weighted Average Shares Out |
$25.44 M
|
$17.94 M
|
$4.60 M
|
$4.54 M
|
$4.44 M
|
$17.43 M
|
| Weighted Average Shares Out Diluted |
$25.44 M
|
$17.94 M
|
$4.60 M
|
$4.54 M
|
$4.44 M
|
$17.43 M
|
| Link |
|
|
|
|
|
|
